Caracterização biológica e molecular de quatro cepas de Trypanosoma cruzi Chagas,1909 (Kinetoplastida, Trypanosomatidae) isoladas de pacientes chagásicos crônicos

Pós-graduação em Biociências e Biotecnologia Aplicadas à Farmácia - FCFAR

Extratos padronizados para o tratamento de doenças crônicas: Arrabidaea spp

Pós-graduação em Química - IQ

Mito, história e memória em Órfãos do Eldorado de Milton Hatoum

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Determinantes e indicadores de eco-inovação

This study aimed to gather the determinants and indicators of environmental innovations through a literature review on the topic. But before it was made a presentation of concepts and typology of eco-innovation, with different points of view. The determinant more found by most authors was regulation, followed by market factors, cost reductions and company image. To highlight these determinants were presented some cases studies, including evidence in Brazil. Due to the short bibliography and case studies, there are few indicators of environmental innovation found, highlighting the investment in environmental R&D and patents

Bioimperialismo e direito de propriedade intelectual: disputas pelo acesso ao cupuaçu e ao conhecimento tradicional

Pós-graduação em Ciências Sociais - FFC

Estratégias tecnológicas em transformação: um estudo da indústria farmacêutica brasileira

The aim of this research is to analyze the extension of changes in technological strategies of a group of Brazilian pharmaceutical companies, which we believe were induced by transformations in the institutional environment during the 1990s. Major institutional changes, such as the enacting of laws that recognized drug patents rights and fostered generic drugs market, have strengthened the market insertion and competitive position of these companies, what would enable an increase in research and development efforts in Brazil. In addition to the literature on technology strategy and drug industry, this study was based on interviews with six Brazilian pharmaceutical companies, all of which were ranked among the top national companies in the industry and have been considered in previous studies particularly active in the process of changing technological strategies. This research confirmed a significant intensification of technology efforts carried out by Brazilian drug companies. Nevertheless, the R&D intensity is still far below the global pattern and innovative impacts are slight.

Análise econômica da produção de soja rr2 pro e soja rr1: estudo de caso no Estado de Mato Grosso

Pós-graduação em Agronomia (Energia na Agricultura) - FCA

Inovação e pesquisa em design nas universidades brasileiras

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Licenciamento provisório da patente: inibidores de protease no tratamento da Hepatite C crônica

Pós-graduação em Pesquisa e Desenvolvimento (Biotecnologia Médica) - FMB

As relações socioculturais no Mercado Municipal de São Paulo: produção de tradições na formação e no reconhecimento de grupos culturais a partir da alimentação

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)